Document Detail


Previously unsuspected widespread cellular and tissue distribution of β-adrenoceptors and its relevance to drug action.
MedLine Citation:
PMID:  21429599     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The discovery of β-adrenoceptors in previously unsuspected cell types is contributing to the rethinking of new drug targets. Recent developments in β-adrenoceptor pharmacology might have excited and surprised James Black, given his interest in developing drugs based on the selective manipulation of receptors to alter physiological responses. β-adrenoceptors continue to generate surprises at molecular and pharmacological levels that often require knowledge of receptor location to interpret. In this review, we emphasize the use of fluorescent ligands as the most selective means of demonstrating receptor localization. Fluorescent ligand binding in live tissues can provide quantitative pharmacological data, under carefully controlled conditions, relevant to other signalling parameters. Consideration of the role of β-adrenoceptors in many cell types (previously ignored) is needed to understand the actions of drugs at β-adrenoceptors throughout the body, particularly in the lung epithelium, vascular endothelium, immune cells and other 'structural' and 'restorative' cell types.
Authors:
C J Daly; J C McGrath
Related Documents :
24631899 - Anti-mycobacterial activity of 1,3-diaryltriazenes.
21216589 - The acridone derivative mbli-87 sensitizes breast cancer resistance protein-expressing ...
21528349 - In vitro schedule-dependent interaction between paclitaxel and vinorelbine in a2780 par...
21343459 - Differential drug efflux or accumulation does not explain variation in the chloroquine ...
21490679 - Special delivery: targeted therapy with small rnas.
21241199 - Role of organic cation transporters in drug-induced toxicity.
10675699 - Silica xerogel carrier material for controlled release of toremifene citrate.
2026219 - Plasmodium berghei: quantitation of in vitro effects of antimalarial drugs on exoerythr...
19774739 - Novel biospecific agents for the treatment of myelodysplastic syndromes.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-21
Journal Detail:
Title:  Trends in pharmacological sciences     Volume:  -     ISSN:  1873-3735     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7906158     Medline TA:  Trends Pharmacol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Affiliation:
School of Life Sciences, College of Medical, Veterinary and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12 8QQ, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evolution of ?-blockers: from anti-anginal drugs to ligand-directed signalling.
Next Document:  Pharmacological management of GERD: where does it stand now?